| Financial Year |
March 31 2023 |
| Monetary Funds |
10,808,790,935.67 |
| Held-for-trading Financial Assets |
3,298,503,047.33 |
| Notes Receivable |
903,662,425.63 |
| Accounts Receivable |
14,693,106,214.13 |
| Advances to Suppliers |
759,957,921.70 |
| Other Receivables |
1,412,379,830.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
18,729,765,030.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
53,713,000.00 |
| Other Current Assets |
951,243,973.96 |
| Total Current Assets |
53,843,748,547.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
344,460,000.00 |
| Long-term Equity Investment |
230,733,794.19 |
| Investment Properties |
-- |
| Fixed Assetes |
4,968,326,499.21 |
| Under-construction Projects |
948,899,396.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
383,735,363.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
98,323,780.37 |
| Deferred Income Tax Assets |
1,251,212,843.57 |
| Other Non-Current Assets |
1,260,701,762.50 |
| Sub-Total of Non-Current Assets |
10,326,139,873.11 |
| Total Assets |
64,169,888,420.51 |
| Short-Term Loans |
2,804,259,710.97 |
| Trading Financial liabilities |
33,024,372.88 |
| Notes Payable |
14,219,669,940.11 |
| Accounts Payable |
10,375,587,796.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
431,076,902.77 |
| Taxes Payable |
751,783,568.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,119,715,192.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
897,245,994.58 |
| Other Current Liabilities |
1,195,575,821.60 |
| Sub-Total of Current Liabilities |
35,742,216,279.40 |
| Long-term Loans |
4,494,489,303.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
658,892,106.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,298,268,632.95 |
| Deferred Income Tax Liabilities |
79,664,122.03 |
| Other Non-Current Liabilities |
48,176,023.60 |
| Sub-Total of Non-Current Liabilities |
7,153,189,982.76 |
| Total Liabilities |
42,895,406,262.16 |
| Paid-In Capital(Or Share Stock) |
1,485,190,984.00 |
| Capital Surplus |
7,092,479,853.24 |
| Surplus Reserve |
1,066,201,017.69 |
| LESS:Treasury Stock |
520,749,625.73 |
| Undistributed Profits |
11,120,991,882.08 |
| Minority Stockholder's Interest |
1,094,675,941.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,179,806,216.80 |
| Owner's Equity（Stockholder's Equity） |
21,274,482,158.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
64,169,888,420.51 |
